LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
20.01 21.74 1553 901 1.7219 1.2128
MN20160310_N01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 38 1108 0.0343 0.1035
MN20160310_N01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 1758 1108 1.5861 1.1695
MN20160310_N01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 1 1108 0.0009 -0.4189
MN20160310_N01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 1708 1108 1.5410 1.1584
MN20160310_N01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 898 1108 0.8102 0.9272
MN20160310_N01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 1724 1108 1.5555 1.1620
MN20160310_N01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 21 1108 0.0189 -0.0061
MN20160310_N01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
21.98 21.74 1697 1108 1.5311 1.1560
MN20160310_N01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 32 1354 0.0236 0.0670
MN20160310_N01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 1844 1354 1.3613 1.1062
MN20160310_N01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 4 1354 0.0030 -0.2472
MN20160310_N01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 1784 1354 1.3170 1.0946
MN20160310_N01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 1421 1354 1.0490 1.0161
MN20160310_N01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 1835 1354 1.3547 1.1045
MN20160310_N01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 29 1354 0.0214 0.0495
MN20160310_N01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
23.95 21.74 1809 1354 1.3355 1.0994
MN20160310_N01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 64 1515 0.0422 0.1928
MN20160310_N01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 2029 1515 1.3387 1.0976
MN20160310_N01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 2 1515 0.0013 -0.3227
MN20160310_N01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 2002 1515 1.3209 1.0930
MN20160310_N01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 1614 1515 1.0649 1.0206
MN20160310_N01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 1978 1515 1.3051 1.0889
MN20160310_N01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 37 1515 0.0244 0.0907
MN20160310_N01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
25.92 21.74 1961 1515 1.2938 1.0859
MN20160310_N01
N21